Search alternatives:
significant infection » significant interaction (Expand Search), significant connection (Expand Search), significant interactions (Expand Search)
infection increase » infection increases (Expand Search), infection incidence (Expand Search), infection disease (Expand Search)
larger decrease » marked decrease (Expand Search)
lower decrease » linear decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
Showing 141 - 160 results of 37,715 for search '(( significantly ((lower decrease) OR (larger decrease)) ) OR ( significant infection increase ))', query time: 1.03s Refine Results
  1. 141
    Posttreatment facial, intraoral photographs, and radiographs of the case with mandibular third molar extraction.

    Posttreatment facial, intraoral photographs, and radiographs of the case with mandibular third molar extraction. by Lijuan Liu (136685)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 142
    Comparison of pretreatment cephalometric variables between premolar extraction and mandibular third molar extraction groups.

    Comparison of pretreatment cephalometric variables between premolar extraction and mandibular third molar extraction groups. by Lijuan Liu (136685)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 143
    Demographic characteristics of study participants.

    Demographic characteristics of study participants. by Lijuan Liu (136685)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 144
    Results of Analysis of Co-variance (ANCOVA) for change in parameter predicted by treatment group with pre-treatment value as a covariate. * p < 0.05; ** p < 0.01.

    Results of Analysis of Co-variance (ANCOVA) for change in parameter predicted by treatment group with pre-treatment value as a covariate. * p < 0.05; ** p < 0.01. by Lijuan Liu (136685)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 145
    Comparison of treatment effects between premolar extraction and mandibular third molar extraction groups. * p < 0.05; ** p < 0.01.

    Comparison of treatment effects between premolar extraction and mandibular third molar extraction groups. * p < 0.05; ** p < 0.01. by Lijuan Liu (136685)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 146
    Intraoperative facial and intraoral photographs of the case with mandibular third molar extraction.

    Intraoperative facial and intraoral photographs of the case with mandibular third molar extraction. by Lijuan Liu (136685)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 147
    Pretreatment facial, intraoral photographs, and radiographs of the case with premolar tooth extraction.

    Pretreatment facial, intraoral photographs, and radiographs of the case with premolar tooth extraction. by Lijuan Liu (136685)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 148
    Pretreatment facial, intraoral photographs, and radiographs of the case with mandibular third molar extraction.

    Pretreatment facial, intraoral photographs, and radiographs of the case with mandibular third molar extraction. by Lijuan Liu (136685)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 149
    Compressed sensing decoded pooled testing significantly decreases the number of tests required to identify infected samples.

    Compressed sensing decoded pooled testing significantly decreases the number of tests required to identify infected samples. by Kody A. Waldstein (14002708)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  10. 150
    The results of KEGG enrichment analysis (Annotation: Circles represent each pathway, and the redder the color, the larger the circle, and the more important it is).

    The results of KEGG enrichment analysis (Annotation: Circles represent each pathway, and the redder the color, the larger the circle, and the more important it is). by Lin Zhou (141050)

    Published 2023
    Save to List
    Saved in:
  11. 151
    DENV infection significantly reduces intracellular acylcarnitine levels.

    DENV infection significantly reduces intracellular acylcarnitine levels. by Li Xu (108702)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  12. 152
    Traits at cellular, leaf, and whole-plant scales which were significantly different [increased (↑) or decreased (↓)] or non-significant between tolerant and sensitive cultivars in the N-deficient treatment.

    Traits at cellular, leaf, and whole-plant scales which were significantly different [increased (↑) or decreased (↓)] or non-significant between tolerant and sensitive cultivars in... by Ranjeeta Adhikari (9905958)

    Published 2023
    Save to List
    Saved in:
  13. 153
    CBP per cumulative year for daratumumab and pembrolizumab per vial.

    CBP per cumulative year for daratumumab and pembrolizumab per vial. by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  14. 154
    S4 Fig -

    S4 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  15. 155
    S1 Fig -

    S1 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  16. 156
    S5 Fig -

    S5 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  17. 157
    Scenario analysis for pembrolizumab using a cumulative cost-based price per year per vial.

    Scenario analysis for pembrolizumab using a cumulative cost-based price per year per vial. by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  18. 158
    S3 Fig -

    S3 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  19. 159
    S6 Fig -

    S6 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  20. 160
    CBP per cumulative indication for daratumumab and pembrolizumab per vial.

    CBP per cumulative indication for daratumumab and pembrolizumab per vial. by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:

Search Tools: